| 000 | 01118 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513225839.0 | ||
| 264 | 0 | _c20010202 | |
| 008 | 200102s 0 0 fre d | ||
| 022 | _a0399-8320 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLoubière, S | |
| 245 | 0 | 0 |
_a[Medico-economic assessment of the therapeutic management of patients with hepatitis C]. _h[electronic resource] |
| 260 |
_bGastroenterologie clinique et biologique _cNov 2000 |
||
| 300 |
_a1047-51 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; English Abstract; Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCost of Illness |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aHepatitis C _xcomplications |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aRotily, M | |
| 700 | 1 | _aMoatti, J P | |
| 773 | 0 |
_tGastroenterologie clinique et biologique _gvol. 24 _gno. 11 _gp. 1047-51 |
|
| 999 |
_c11079736 _d11079736 |
||